用全基因组测序对患有神经发育障碍的儿童进行遗传诊断
Sunghwan Shin1, Jiwon Lee2, Young-Gon Kim3
1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Laboratory Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
Pediatric neurology
|September 30, 2023
概括
全基因组测序 (WGS) 有助于诊断神经发育障碍 (NDD). 三位分析有效地识别了新变异 (DNV),改善了复杂遗传疾病的诊断产量.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 儿科 儿科 儿科
背景情况:
- 神经发育障碍 (NDD) 呈现多种现象,由于各种遗传原因,复杂的遗传诊断.
- 准确的基因鉴定NDD的致病基因仍然是一个挑战.
研究的目的:
- 实施全基因组测序 (WGS) 用于在患有NDD的儿科患者中进行遗传诊断.
- 评估WGS在患有NDD的儿童队列中的诊断效用.
主要方法:
- 全基因组测序 (WGS) 在78名患有NDD的儿科患者和152名家庭成员身上进行.
- 基于三项分析的分析被用于变体解释,使用ACMG指南分类变体.
- 之前的基因检测结果可用于75名患者.
主要成果:
- 在78名受试者中,WGS的诊断率为33.3% (26名受试者).
- 三组分析在22个病例中发现了新的变异 (DNV),其中一半是新型.
- WGS检测到结构变异,包括删除和逆转移子插入,并确定了与NDD异质性相一致的基因缺陷.
结论:
- 全基因组测序 (WGS) 为诊断NDD提供了显著的优势.
- 三重测序增强了对新变体 (DNV) 的解释,并有助于检测副本数量变异.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Genomics
36.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.4K
Next-generation Sequencing
89.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
89.8K
Sanger Sequencing
754.7K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
754.7K


